Characteristics Associated with Ventricular Tachyarrhythmias and Their Prognostic Impact in Heart Failure with Mildly Reduced Ejection Fraction

被引:0
|
作者
Schmitt, Alexander [1 ]
Behnes, Michael [1 ]
Rusnak, Jonas [2 ]
Akin, Muharrem [3 ]
Reinhardt, Marielen [1 ]
Abel, Noah [1 ]
Forner, Jan [1 ]
Mueller, Julian [4 ]
Weidner, Kathrin [1 ]
Abumayyaleh, Mohammad [1 ]
Akin, Ibrahim [1 ]
Schupp, Tobias [1 ]
机构
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Med 1,Sect Invas Cardiol, D-68167 Mannheim, Germany
[2] Univ Hosp Heidelberg, Dept Cardiol Angiol & Pneumol, D-69047 Heidelberg, Germany
[3] Ruhr Univ Bochum, St Josef Hosp, Dept Cardiol, D-44791 Bochum, Germany
[4] Univ Freiburg, Univ Heart Ctr Freiburg Bad Krozingen, Fac Med, Dept Cardiol, D-79106 Freiburg, Germany
关键词
heart failure with mildly reduced ejection fraction; HFmrEF; ventricular tachyarrhythmias; ventricular tachycardia; sudden cardiac death; SUDDEN CARDIAC DEATH; ACUTE MYOCARDIAL-INFARCTION; EUROPEAN ASSOCIATION; IMPROVED SURVIVAL; WALL STRESS; DEFIBRILLATOR; TACHYCARDIA; ARRHYTHMIAS; OUTCOMES; PREVENTION;
D O I
10.3390/jcm13092665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The occurrence of ventricular tachyarrhythmias represents an established risk factor of mortality in heart failure (HF). However, data concerning their prognostic impact in heart failure with mildly reduced ejection fraction (HFmrEF) is limited. Therefore, the present study aims to investigate patient characteristics associated with ventricular tachyarrhythmias and their prognostic impact in patients with HFmrEF. Methods: Consecutive patients hospitalized with HFmrEF (i.e., left ventricular ejection fraction 41-49% and signs and/or symptoms of HF) were retrospectively included at one institution from 2016 to 2022. The prognosis of patients with HFmrEF and different types of ventricular tachyarrhythmias (i.e., non-sustained ventricular tachycardia (nsVT), sustained VT (sVT), and ventricular fibrillation (VF) was investigated for the primary endpoint of long-term all-cause mortality at 30 months. Secondary endpoints included in-hospital all-cause mortality and long-term HF-related rehospitalization at 30 months. Results: From a total of 2184 patients with HFmrEF, 4.4% experienced ventricular tachyarrhythmias (i.e., 2.0% nsVT, 0.7% sVT, and 1.6% VF). The occurrence of nsVT was associated with higher New York Heart Association (NYHA) functional class, whereas the incidence of sVT/VF was associated with acute myocardial infarction and ischemic heart disease. However, nsVT (25.0%; HR = 0.760; 95% CI 0.419-1.380; p = 0.367) and sVT/VF (28.8%; HR = 0.928; 95% CI 0.556-1.549; p = 0.776) were not associated with a higher risk of long-term all-cause mortality compared to patients with HFmrEF without ventricular tachyarrhythmias (31.5%). In-hospital cardiovascular mortality was more frequently observed in patients with HFmrEF and sVT/VF compared to those with HFmrEF but without sustained ventricular tachyarrhythmias (7.7% vs. 1.5%; p = 0.004). Finally, the risk of rehospitalization for worsening HF was not affected by the presence of ventricular tachyarrhythmias. Conclusions: The occurrence of ventricular tachyarrhythmias in patients hospitalized with HFmrEF was low and not associated with long-term prognosis.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
    Solomon, Scott D.
    McMurray, John J. V.
    Vaduganathan, Muthiah
    Claggett, Brian
    Jhund, Pardeep S.
    Desai, Akshay S.
    Henderson, Alasdair D.
    Lam, Carolyn S. P.
    Pitt, Bertram
    Senni, Michele
    Shah, Sanjiv J.
    Voors, Adriaan A.
    Zannad, Faiez
    Abidin, Imran Zainal
    Alcocer-Gamba, Marco Antonio
    Atherton, John J.
    Bauersachs, Johann
    Chang-Sheng, Ma
    Chiang, Chern-En
    Chioncel, Ovidiu
    Chopra, Vijay
    Comin-Colet, Josep
    Filippatos, Gerasimos
    Fonseca, Candida
    Gajos, Grzegorz
    Goland, Sorel
    Goncalvesova, Eva
    Kang, Seokmin
    Katova, Tzvetana
    Kosiborod, Mikhail N.
    Latkovskis, Gustavs
    Lee, Alex Pui-Wai
    Linssen, Gerard C. M.
    Llamas-Esperon, Guillermo
    Mareev, Vyacheslav
    Martinez, Felipe A.
    Melenovsky, Vojtech
    Merkely, Bela
    Nodari, Savina
    Petrie, Mark C.
    Saldarriaga, Clara Ines
    Saraiva, Jose Francisco Kerr
    Sato, Naoki
    Schou, Morten
    Sharma, Kavita
    Troughton, Richard
    Udell, Jacob A.
    Ukkonen, Heikki
    Vardeny, Orly
    Verma, Subodh
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [22] Clinical characteristics and outcomes in Asian patients with heart failure with mildly reduced ejection fraction
    Tay, Julian Cheong Kiat
    Chia, Shaw Yang
    Koh, Siew Hui Michelle
    Sim, David Kheng Leng
    Chai, Ping
    Loh, Seet Yoong
    Jaufeerally, Fazlur Rehman
    Lee, Sheldon Shao Guang
    Lim, Patrick Zhan Yun
    Yap, Jonathan
    SINGAPORE MEDICAL JOURNAL, 2024, 65 (07) : 389 - 396
  • [23] Comment on: Incident Heart Failure With Mildly Reduced Ejection Fraction: Frequency, Characteristics, and Outcomes
    Zahid, Ayesha
    Ikram, Jibran
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (11)
  • [24] Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure
    Savarese, Gianluigi
    Gatti, Paolo
    Benson, Lina
    Adamo, Marianna
    Chioncel, Ovidiu
    Crespo-Leiro, Maria G.
    Anker, Stefan D.
    Coats, Andrew J. S.
    Filippatos, Gerasimos
    Lainscak, Mitja
    McDonagh, Theresa
    Mebazaa, Alexandre
    Metra, Marco
    Piepoli, Massimo F.
    Rosano, Giuseppe M. C.
    Ruschitzka, Frank
    Seferovic, Petar
    Volterrani, Maurizio
    Maggioni, Aldo P.
    Lund, Lars H.
    AMERICAN HEART JOURNAL, 2024, 267 : 52 - 61
  • [25] Prognostic impact of hyperuricemia in chronic heart failure with reduced ejection fraction
    Catarina Carvalho, C.
    Bernardo, M.
    Moreira, I.
    Baptista, A.
    Moreira, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 79 - 79
  • [26] Prognostic Implications of Type 2 Diabetes Mellitus in Heart Failure with Mildly Reduced Ejection Fraction
    Schupp, Tobias
    Abumayyaleh, Mohammad
    Weidner, Kathrin
    Lau, Felix
    Reinhardt, Marielen
    Abel, Noah
    Schmitt, Alexander
    Forner, Jan
    Ayasse, Niklas
    Bertsch, Thomas
    Akin, Muharrem
    Akin, Ibrahim
    Behnes, Michael
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [27] Right ventricular performance in patients with heart failure with mildly reduced ejection fraction: the forgotten ventricle
    Konstantinos Koutsampasopoulos
    Ioannis Vogiatzis
    Antonios Ziakas
    Christodoulos Ε. Papadopoulos
    Charalampos Loutradis
    Konstantinos P. Imprialos
    Konstantinos Stavropoulos
    Vasilios Vasilikos
    Vasilios G. Athyros
    Asterios Karagiannis
    Michael Doumas
    Vasilios Papademetriou
    The International Journal of Cardiovascular Imaging, 2022, 38 : 2363 - 2372
  • [28] Right ventricular performance in patients with heart failure with mildly reduced ejection fraction: the forgotten ventricle
    Koutsampasopoulos, Konstantinos
    Vogiatzis, Ioannis
    Ziakas, Antonios
    Papadopoulos, Christodoulos E.
    Loutradis, Charalampos
    Imprialos, Konstantinos P.
    Stavropoulos, Konstantinos
    Vasilikos, Vasilios
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Doumas, Michael
    Papademetriou, Vasilios
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2022, 38 (11): : 2363 - 2372
  • [29] Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
    Peters, Anthony E.
    Clare, Robert M.
    Chiswell, Karen
    Felker, G. Michael
    Kelsey, Anita
    Mentz, Robert
    DeVore, Adam D.
    CIRCULATION-HEART FAILURE, 2023, 16 (05) : 377 - 388
  • [30] Vascular Dysfunction Predicts Future Deterioration of Left Ventricular Ejection Fraction in Patients with Heart Failure with Mildly Reduced Ejection Fraction
    Kishimoto, Shinji
    Maruhashi, Tatsuya
    Kajikawa, Masato
    Harada, Takahiro
    Yamaji, Takayuki
    Han, Yiming
    Mizobuchi, Aya
    Hashimoto, Yu
    Yoshimura, Kenichi
    Nakano, Yukiko
    Chayama, Kazuaki
    Goto, Chikara
    Yusoff, Farina Mohamad
    Nakashima, Ayumu
    Higashi, Yukihito
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)